Tacrolimus intrapatient variability and latent virus reactivation after kidney transplantation: A retrospective study comparing prolonged-release and immediate-release tacrolimus formulations.

J Int Med Res · 2026 · PMC13338517 · PMID 42403167

Europe PMC DOI

hedged sentence

0.1240

closest p · 2.5× alpha

0.1240

boldest claim

The sentences

a nonsignificant trendp = 0.124not close (p > 0.1)

Tacrolimus formulation (IR vs PR) showed a nonsignificant trend toward a higher risk (OR = 3.43, 95% CI: 0.71–16.46, p = 0.124).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.